Castleark Management LLC Pacira Bio Sciences, Inc. Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$51.49 - $81.64 $570,509 - $904,571	-11,080 Reduced 18.27%	49,580 $2.89 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $3.64 Million - $4.64 Million	60,660 New	60,660 $4.63 Million
Q1 2019 May 14, 2019	SELL	$36.47 - $42.17 $4.36 Million - $5.04 Million	-119,440 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$41.31 - $52.16 $4.38 Million - $5.53 Million	-106,105 Reduced 47.04%	119,440 $5.14 Million
Q3 2018 Nov 15, 2018	BUY	$32.85 - $52.0 $7.41 Million - $11.7 Million	225,545 New	225,545 $11.1 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.